Mayo Clinic Comprehensive Cancer Center was one of the first cancer centers to receive the NCI designation in 1973. Today, it is the only NCI-Designated Comprehensive Cancer Center with three locations in Arizona, Florida, and Minnesota.
For more than 50 years, Mayo Clinic has helped transform the nation's cancer research efforts by focusing on a team approach to find new and better ways to prevent, intercept, diagnose and treat cancer. Every year, more than 130,000 people with cancer come to Mayo Clinic from all walks of life and from around the world to receive precision diagnoses and treatments tailored to their exact needs and cancer types.
Read more about the Mayo Clinic Comprehensive Cancer Center.
Mayo Clinic
Comp
Cheryl L. Willman, MD
Director
Director
200 First Street, S.W
Rochester, MN 55905
Rochester, MN 55905
(507) 266-4997
Senior Leaders
| Senior Leader | Title |
|---|---|
| Bruce F Horazdovsky, PhD | Enterprise Deputy Director, Research Education and Training |
| Cheryl L Willman, MD | Director and Principal Investigator; Enterprise Executive Director, Mayo Clinic Cancer Programs and Mayo Clinic Comprehensive Cancer Center |
| Cui Tao, PhD | Enterprise Co-Deputy Director, Data Science/Artificial Intelligence |
| Daniel D Billadeau, PhD | Enterprise Deputy Director, Basic Research |
| Daniel D Billadeau, PhD | Enterprise Deputy Director, Shared Resources |
| Eric W Klee, PhD | Enterprise Co-Deputy Director, Data Science/Artificial Intelligence |
| Felicity T Enders, PhD | Enterprise Deputy Director, Diversity, Equity, and Inclusion |
| Folakemi Odedina, PhD | Enterprise Deputy Director, Community Outreach and Engagement |
| Grzegorz S Nowakowski, MD | Enterprise Deputy Director, Clinical Research |
| James R Cerhan, MD, PhD | Enterprise Deputy Director, Population Sciences |
| Jolene M Summer Bolster, MA | Enterprise Deputy Director for Administration |
| Matthew P Goetz, MD | Enterprise Deputy Director, Translational Research |
| Richard J Bold, MD, MBA | Site Deputy Director, Arizona |
| Roxana S Dronca, MD | Site Deputy Director, Florida |
| Stephen M Ansell, MD, PhD | Site Deputy Director, Rochester/Midwest; Enterprise Deputy Director |
| TBN | Enterprise Associate Director for Administration |
Research Programs
| Research Program | Program Leaders |
|---|---|
| Advanced Clinical Trials and Translational Sciences | Tanios Bekaii-Saab, MD; Leif Bergsagel, MD; Amy Degnim, MD; Jann Sarkaria, MD |
| Cancer Cell Genomics, Signaling and Metastasis | Panos Anastasiadis, PhD; Zhenkun Lou, PhD; Mark McNiven, PhD |
| Cancer Immunology and Immunotherapeutics | Saad Kenderian, MB, CHB; Keith Knutson, PhD; Virginia Shaprio, PhD |
| Cancer Prevention, Control, and Survivorship | Janice Krieger, PhD; Kathryn Ruddy, MD; Lila Rutten, PhD |
| Cancer Risk Assessment, Early Detection and Interception | Ajit Goenka, MD; Shaji Kumar, MD; Mark Sherman, PhD |
| Novel Therapeutics and Therapeutic Modalitities | Mitesh Borad, MD; Scott Kaufmann, MD,PhD; Virginia Shapiro, PhD |
Shared Resources
| Category | Resource | Directors |
|---|---|---|
| Cat 1: Laboratory Science | Genome Analysis | Stephen Murphy, PhD |
| Cat 1: Laboratory Science | Immune Monitoring | JC Villaboas Bisneto, MD |
| Cat 1: Laboratory Science | Microscopy and Cell Analysis | Jeffrey Salisbury, PhD |
| Cat 1: Laboratory Science | Pharmacology | Joel Reid, PhD |
| Cat 1: Laboratory Science | Proteomics | Akhilesh Pandey, MD, PhD |
| Cat 1: Laboratory Science | Transgenic and Knockout | Darren Baker, PhD |
| Cat 3: Epidemiology, Cancer Control | Survey Research | Kathleen Yost, PhD |
| Cat 4: Clinical Research | Biospecimens Accessioning and Processing | Mine Cicek, PhD |
| Cat 4: Clinical Research | Pathology Research | Thomas Flotte, MD |
| Cat 6: Biostatistics | Biostatistics | Karla Ballman, PhD |
| Cat 7: Informatics | Bioinformatics | Karla Ballman, PhD |
Last Updated
April 24, 2025